THE first Indian nationwide survey of spurious and not-of-standard quality drugs in the domestic market, commenced by the Central government in 2014, is almost completed and will be submitted to the Health ministry by the end of this year, pharmabiz.com has reported.
The survey is being carried out on 48,000 drug samples collected from different parts of the country by engaging almost 1000 drug inspectors.
The survey will investigate 224 molecules across 15 major therapeutic drug groups relevant to the Indian market with the Indian Statistical Institute and National Sample Survey Organisation developing a unique statistical design for the purpose.
Early indications from the survey suggest that presence of sub-standard drugs in the domestic market has come down from 8% to 4.5%.
The above article was sent to subscribers in Pharmacy Daily's issue from 21 Sep 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Sep 16
